|
Apoptosis Regulator BAX (Bcl 2 Like Protein 4 or BCL2L4 or BAX) - Pipeline Review, H2 2018 |
Nov 20 2018 |
44 |
Global |
$3,500.00 |
|
|
T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H2 2018 |
Nov 20 2018 |
77 |
Global |
$3,500.00 |
|
|
Integrin Beta 1 (Fibronectin Receptor Subunit Beta or Glycoprotein Iia or VLA 4 Subunit Beta or CD29 or ITGB1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
57 |
Global |
$3,500.00 |
|
|
Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline Review, H2 2018 |
Nov 20 2018 |
67 |
Global |
$3,500.00 |
|
|
Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
35 |
Global |
$3,500.00 |
|
|
Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2018 |
Nov 20 2018 |
48 |
Global |
$3,500.00 |
|
|
Radiodermatitis - Pipeline Review, H2 2018 |
Nov 20 2018 |
36 |
Global |
$2,000.00 |
|
|
Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
68 |
Global |
$3,500.00 |
|
|
Diabetic Foot Ulcers - Pipeline Review, H2 2018 |
Nov 20 2018 |
138 |
Global |
$2,000.00 |
|
|
cAMP and cAMP Inhibited cGMP 3',5' Cyclic Phosphodiesterase 10A (Phosphodiesterase 10A1 or Phosphodiesterase 10A7 or PDE10A or EC 3.1.4.17 or EC 3.1.4.35) - Pipeline Review, H2 2018 |
Nov 20 2018 |
36 |
Global |
$3,500.00 |
|
|
T Lymphocyte Activation Antigen CD80 (Activation B7-1 Antigen or CTLA 4 Counter Receptor B7.1 or CD80) - Pipeline Review, H2 2018 |
Nov 20 2018 |
79 |
Global |
$3,500.00 |
|
|
Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
32 |
Global |
$3,500.00 |
|
|
Integrin Alpha V (Vitronectin Receptor Subunit Alpha or CD51 or ITGAV) - Pipeline Review, H2 2018 |
Nov 20 2018 |
86 |
Global |
$3,500.00 |
|
|
Phenylalanine 4 Hydroxylase (Phe 4 Monooxygenase or PAH or EC 1.14.16.1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
40 |
Global |
$3,500.00 |
|
|
Serine/Threonine Protein Kinase Pim 2 (Pim 2h or Proto Oncogene Pim 2 or PIM2 or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
39 |
Global |
$3,500.00 |
|
|
Protein Kinase C Theta Type (nPKC Theta or PRKCQ or EC 2.7.11.13) - Pipeline Review, H2 2018 |
Nov 20 2018 |
35 |
Global |
$3,500.00 |
|
|
Serine/Threonine Protein Kinase Pim 1 (Oncogene PIM1 or PIM1 or EC 2.7.11.1) - Pipeline Review, H2 2018 |
Nov 20 2018 |
47 |
Global |
$3,500.00 |
|
|
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Pipeline Review, H2 2018 |
Nov 20 2018 |
51 |
Global |
$3,500.00 |
|
|
Diabetic Neuropathy - Pipeline Review, H2 2018 |
Nov 20 2018 |
118 |
Global |
$2,000.00 |
|
|
Hepatitis A Virus Cellular Receptor 2 (T Cell Immunoglobulin And Mucin Domain Containing Protein 3 or T Cell Immunoglobulin Mucin Receptor 3 or T Cell Membrane Protein 3 or CD366 or HAVCR2) - Pipeline Review, H2 2018 |
Nov 20 2018 |
64 |
Global |
$3,500.00 |
|
|
Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2018 |
Nov 20 2018 |
52 |
Global |
$3,500.00 |
|
|
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H2 2018 |
Nov 13 2018 |
143 |
Global |
$3,500.00 |
|
|
Lung Transplant Rejection - Pipeline Review, H2 2018 |
Nov 13 2018 |
73 |
Global |
$2,000.00 |
|
|
Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H2 2018 |
Nov 13 2018 |
69 |
Global |
$3,500.00 |
|
|
Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Pipeline Review, H2 2018 |
Nov 13 2018 |
140 |
Global |
$3,500.00 |
|
|
Aspergillosis - Pipeline Review, H2 2018 |
Nov 13 2018 |
140 |
Global |
$2,000.00 |
|
|
Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Pipeline Review, H2 2018 |
Nov 13 2018 |
74 |
Global |
$2,000.00 |
|
|
Tyrosine Protein Kinase Fyn (Proto Oncogene Syn or Proto Oncogene c Fyn or Src Like Kinase or p59 Fyn or FYN or EC 2.7.10.2) - Pipeline Review, H2 2018 |
Nov 13 2018 |
79 |
Global |
$3,500.00 |
|
|
Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections - Pipeline Review, H2 2018 |
Nov 13 2018 |
42 |
Global |
$2,000.00 |
|
|
Hypoparathyroidism - Pipeline Review, H2 2018 |
Nov 13 2018 |
51 |
Global |
$2,000.00 |
|
